Bafrani, Mahdie Arab
Nourizadeh, Roghaiyeh
Hakimi, Sevil
Mortazavi, Seyed Alireza
Mehrabi, Esmat
Article History
Received: 10 March 2023
Accepted: 27 May 2024
First Online: 29 May 2024
Declarations
:
: The ethics committee of Tabriz University of Medical Sciences, Tabriz, East Azerbaijan Province, Iran approved this study (IR.TBZMED.REC.1400.677) and it was registeredin the Iranian Registry of Clinical Trials (IRCT code: IRCT20171007036615N8). Written informed consent was obtained from all individual participants who participated in the study. In present study all methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.